Human colorectal carcinoma cells in vitro as a means to assess the metabolism of analogs of mycophenolic acid

Drug Metabolism and Disposition

Volumn 25, Issue 3, 1997, Pages 367-370

  Franklin, Trevor J ^a   Jacobs, Vivien N ^b   Jones, Geraint ^b   Ple, Patrick ^b  

^a ASTRAZENECA   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE; MYCOPHENOLIC ACID;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOSTASIS; DOSE RESPONSE; DRUG METABOLISM; GLUCURONIDATION; HUMAN; HUMAN CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; GLUCURONATES; HT29 CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0030948151     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. T. J. Franklin and J. M. Cook: The inhibition of nucleic acid synthesis by m mycophenolic acid. Biochem. J. 113, 515-524 (1969).
2. S. F. Carr, E. Papp, J. C. Wu, and Y. Natsumeda: Characterization of human type I and type II IMP dehydrogenase. J. Biol. Chem. 268, 27286-27290 (1993).
3. M. D. Sintchak, M. A. Fleming, O. Futer, Raybuck, S. P. Chambers, P. R. Caron, M. A. Murcko, and K. P. Wilson: Structure and mechanism of inosine monophosphate dehydrogenase complex with the immunosuppressant mycophenolic acid. Cell 85, 921-930 (1996).
4. H. W. Solinger: Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60, 225-232 (1995).
5. L. M. Shaw, H. W. Solinger, P. Halloran, R. E. Morris, R. W. Yatscoff, J. Ransom, I. Tsina, P. Keown, D. W. Holt, R. Lieberman, A. Jaklitsch, and J. Potter: Mycophenolate mofetil: a report of the consensus panel. Therapeut. Drug Monit. 17, 690-699 (1995).
6. T. J. Franklin, V. Jacobs, G. Jones, P. Plé, and P. Bruneau: Glucuronidation associated with intrinsic resistance to mycophenolic acid in human colorectal carcinoma cells. Cancer Res. 56, 984-987 (1996).
7. M. S. Mirrlees, S. J. Moulton, C. T. Murphy, and P. J. Taylor: Direct measurement of octanol-water partition coefficients by high-pressure liquid chromatography. J. Med. Chem. 19, 615-619 (1976).
8. B. Fulton and A. Markham: Mycophenolate mofetil. A review of its pharmacological and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 51, 278-298 (1996).
9. W. W. Epinette, C. M. Parker, E. L. Jones, and M. C. Greist: Mycophenolic acid for psoriasis. J. Am. Dermatol. 17, 962-971 (1987).
10. R. Goldblum: Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin. Exp. Pathol. 11 (Suppl. 8), S117-S119 (1993).
11. P. H. Nelson, E. Eugui, C. C. Wang, and A.C. Allison: Synthesis and immunosuppressive activity of some side-chain variants of mycophenolic acid. J. Med. Chem. 33, 833-838 (1990).
12. D. J. Clarke and B. Burchell: The uridinediphosphate glucuronosyl transferase multigene family: function and regulation. In "Handbook of Experimental Pharmacology" (F. C. Kauffman, ed.), vol. 12, pp. 3-43. Springer-Verlag, Berlin, 1994.
13. D. R. Artis, T. R. Elworthy, R. C. Hawley, D. G. Loughhead, D. J. Morgans, P. H. Nelson, J. W. Patterson, J. C. Rohloff, E. B. Sjogren, D. B. Smith, A. M. Waltos, R. J. Weikert, A. C. Garcia, M. F. Zetuche, F. F. Andrade, M. T. L. Hernandez, F. X. T. Murra, and T. A. T. Martin: 5-Substituted derivatives of mycophenolic acid. International Patent Application. Publication No. WO 95/22538, p. 127 (1995).
14. S. Bjorge, K. L. Hamelehle, R. Homan, S. E. Rose, D. A. Turluck, and D. S. Wright: Evidence for glucuronide conjugation of p-nitrophenol in the Caco-2 cell model. Pharmaceut. Res. 8, 1441-1443 (1991).
15. A. Abid, I. Bouchon, G. Siest, and N. Sabolovic: Glucuronidation in the Caco-2 human intestinal cell line: induction of UDP-glucuronosyl transferase 1*6. Biochem. Pharmacol. 50, 557-561 (1995).
16. W. H. N. Peters and H. M. J. Roelofs: Time-dependent activity and expression of glutathione S-transferase in human colon adenocarcinoma cell line Caco-2. Biochem. J. 264, 613-616 (1989).
17. W. H. N. Peters and H. M. J. Roelofs: Biochemical characterization of resistance to mitoxanthone and adriamycin in Caco-2 human adenocarcinoma cells: a possible role for glutathione S-transferases. Cancer Res. 52, 1886-1890 (1992).
18. A. Baranczyk-Kuzma, J. A. Garren, I. M. Hidalgo, and R. T. Borchardt: Substrate specificity and some properties of phenol sulfotransferase from human intestinal Caco-2 cells. Life Sci. 49, 1197-1206 (1991).
19. T. Sergent-Engelen, V. Delistre, and Y.-J. Schneider. Phase I and II biotransformations in living Caco 2 cells cultivated under serum-free conditions. Biochem. Pharmacol. 46, 1393-1401 (1993).